Prevalence and Incidence of Osteoarthritis: A Population-Based Retrospective Cohort Study

Overview

Journal J Clin Med

Specialty General Medicine

Date 2021 Sep 28

PMID 34575394

Citations 27

Authors

Rola Hamood

Matanya Tirosh

Noga Fallach

Gabriel Chodick

Elon Eisenberg

Omri Lubovsky

Affiliations

Soon will be listed here.

Abstract

While trends data of osteoarthritis (OA) are accumulating, primarily from Western Europe and the US, a gap persists in the knowledge of OA epidemiology in Middle Eastern populations. This study aimed to explore the prevalence, incidence, correlations, and temporal trends of OA in Israel during 2013-2018, using a nationally representative primary care database. On 31 December 2018, a total of 180,126 OA patients were identified, representing a point prevalence of 115.3 per 1000 persons (95% CI, 114.8-115.8 per 1000 persons). Geographically, OA prevalence was not uniformly distributed, with the Southern and Northern peripheral districts having a higher prevalence than the rest of the Israeli regions. OA incidence increased over time from 7.36 per 1000 persons (95% CI 6.21-7.50 per 1000 persons) in 2013 to 8.23 per 1000 persons (95% CI 8.09-8.38 per 1000 persons) in 2017 (-value for trend = 0.02). The incidence was lowest in patients under 60 years (in both sexes) and peaked at 60-70 years. In older ages, the incidence leveled off in men and declined in women. The growing risk of OA warrants a greater attention to timely preventive and therapeutic interventions. Further population-based studies in the Middle East are needed to identify modifiable risk factors for timely preventive and therapeutic interventions.

Citing Articles

Prevalence and risk factors of osteoarthritis in patients at a public hospital in Limpopo province.

Masangu T, Tlou B, Dlungwane T S Afr Fam Pract (2004). 2024; 66(1):e1-e6.

PMID: 39625078 PMC: 11622042. DOI: 10.4102/safp.v66i1.5966.

Anti-Inflammatory Activities of Yataprasen Thai Traditional Formulary and Its Active Compounds, Beta-Amyrin and Stigmasterol, in RAW264.7 and THP-1 Cells.

Angsusing J, Singh S, Samee W, Tadtong S, Stokes L, OConnell M Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204123 PMC: 11357128. DOI: 10.3390/ph17081018.

The Effectiveness of a Single Hyaluronic Acid Injection in Improving Symptoms and Muscular Strength in Patients with Knee Osteoarthritis: A Multicenter, Retrospective Study.

Tarantino D, Forte A, Picone A, Sirico F, Ruosi C J Pers Med. 2024; 14(8).

PMID: 39201976 PMC: 11355087. DOI: 10.3390/jpm14080784.

Therapeutic Potential of Olfactory Ensheathing Cells and Adipose-Derived Stem Cells in Osteoarthritis: Insights from Preclinical Studies.

Chang Y, Wu K, Hsu C, Tu T, Liu M, Chiang R Cells. 2024; 13(15.

PMID: 39120281 PMC: 11311847. DOI: 10.3390/cells13151250.

Evaluation of the effect of low-intensity pulsed ultrasound in pain and dysfunction for knee osteoarthritis: a double-blind, randomised controlled trial protocol.

Chen T, He Y, Xia S, Zhou F, Yuan X, Liu X BMJ Open. 2024; 14(7):e082108.

PMID: 38986557 PMC: 11288152. DOI: 10.1136/bmjopen-2023-082108.

References

Felson D, Zhang Y, Anthony J, Naimark A, Anderson J . Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med. 1992; 116(7):535-9. DOI: 10.7326/0003-4819-116-7-535. View

Litwic A, Edwards M, Dennison E, Cooper C . Epidemiology and burden of osteoarthritis. Br Med Bull. 2013; 105:185-99. PMC: 3690438. DOI: 10.1093/bmb/lds038. View

Yu D, Jordan K, Bedson J, Englund M, Blyth F, Turkiewicz A . Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013. Rheumatology (Oxford). 2017; 56(11):1902-1917. PMC: 5850125. DOI: 10.1093/rheumatology/kex270. View

Morgan O, Hillstrom H, Ellis S, Golightly Y, Russell R, Hannan M . Osteoarthritis in England: Incidence Trends From National Health Service Hospital Episode Statistics. ACR Open Rheumatol. 2019; 1(8):493-498. PMC: 6858070. DOI: 10.1002/acr2.11071. View

. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View

Yang Y, You X, Cohen J, Zhou H, He W, Li Z . Sex Differences in Osteoarthritis Pathogenesis: A Comprehensive Study Based on Bioinformatics. Med Sci Monit. 2020; 26:e923331. PMC: 7163332. DOI: 10.12659/MSM.923331. View

Neogi T, Zhang Y . Epidemiology of osteoarthritis. Rheum Dis Clin North Am. 2013; 39(1):1-19. PMC: 3545412. DOI: 10.1016/j.rdc.2012.10.004. View

Shiyovich A, Chodick G, Azani L, Tirosh M, Shuvy M, Pereg D . Sex-specific contemporary trends in incidence, prevalence and survival of patients with non-valvular atrial fibrillation: A long-term real-world data analysis. PLoS One. 2021; 16(2):e0247097. PMC: 7891766. DOI: 10.1371/journal.pone.0247097. View

Al-Awadhi A, Olusi S, Moussa M, Al-Zaid N, Shehab D, Al-Herz A . Validation of the Arabic version of the WHO-ILAR COPCORD Core Questionnaire for community screening of rheumatic diseases in Kuwaitis. World Health Organization. International League Against Rheumatism. Community Oriented Program for the Control of.... J Rheumatol. 2002; 29(8):1754-9. View

10.

Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M . The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014; 73(7):1323-30. DOI: 10.1136/annrheumdis-2013-204763. View

11.

Levkovitch-Verbin H, Goldshtein I, Chodick G, Zigman N, Shalev V . The Maccabi Glaucoma Study: prevalence and incidence of glaucoma in a large israeli health maintenance organization. Am J Ophthalmol. 2014; 158(2):402-408.e1. DOI: 10.1016/j.ajo.2014.04.026. View

12.

Hunter D, Bierma-Zeinstra S . Osteoarthritis. Lancet. 2019; 393(10182):1745-1759. DOI: 10.1016/S0140-6736(19)30417-9. View

13.

Pritzker K, Gay S, Jimenez S, Ostergaard K, Pelletier J, Revell P . Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2005; 14(1):13-29. DOI: 10.1016/j.joca.2005.07.014. View

14.

Davatchi F, Jamshidi A, Tehrani Banihashemi A, Gholami J, Forouzanfar M, Akhlaghi M . WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol. 2008; 35(7):1384. View

15.

Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

16.

Palazzo C, Nguyen C, Lefevre-Colau M, Rannou F, Poiraudeau S . Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med. 2016; 59(3):134-138. DOI: 10.1016/j.rehab.2016.01.006. View

17.

Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H . Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2021; 29-30:100587. PMC: 7704420. DOI: 10.1016/j.eclinm.2020.100587. View

18.

Al-Arfaj A, Alballa S, Al-Saleh S, Al-Dalaan A, Bahabry S, Mousa M . Knee osteoarthritis in Al-Qaseem, Saudi Arabia. Saudi Med J. 2003; 24(3):291-3. View

19.

Safiri S, Kolahi A, Smith E, Hill C, Bettampadi D, Mansournia M . Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020; 79(6):819-828. DOI: 10.1136/annrheumdis-2019-216515. View

20.

Prieto-Alhambra D, Judge A, Javaid M, Cooper C, Diez-Perez A, Arden N . Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis. 2013; 73(9):1659-64. PMC: 3875433. DOI: 10.1136/annrheumdis-2013-203355. View